These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 11832466)

  • 1. Biological actions and therapeutic potential of the glucagon-like peptides.
    Drucker DJ
    Gastroenterology; 2002 Feb; 122(2):531-44. PubMed ID: 11832466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minireview: the glucagon-like peptides.
    Drucker DJ
    Endocrinology; 2001 Feb; 142(2):521-7. PubMed ID: 11159819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glucagon-like peptides--synthesis, biological actions and some clinical implications].
    Otto Buczkowska E; Dworzecki T
    Przegl Lek; 2004; 61(9):947-50. PubMed ID: 15803906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic actions and therapeutic potential of the proglucagon-derived peptides.
    Drucker DJ
    Nat Clin Pract Endocrinol Metab; 2005 Nov; 1(1):22-31. PubMed ID: 16929363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut adaptation and the glucagon-like peptides.
    Drucker DJ
    Gut; 2002 Mar; 50(3):428-35. PubMed ID: 11839727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide 2 function in domestic animals.
    Burrin DG; Stoll B; Guan X
    Domest Anim Endocrinol; 2003 Mar; 24(2):103-22. PubMed ID: 12586312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harnessing the therapeutic potential of glucagon-like peptide-1: a critical review.
    Baggio LL; Drucker DJ
    Treat Endocrinol; 2002; 1(2):117-25. PubMed ID: 15765627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New frontiers in the biology of GLP-2.
    Lovshin J; Drucker DJ
    Regul Pept; 2000 Jun; 90(1-3):27-32. PubMed ID: 10828489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of glucagon-like peptide-1-based pharmaceuticals as therapeutic agents for the treatment of diabetes.
    Drucker DJ
    Curr Pharm Des; 2001 Sep; 7(14):1399-412. PubMed ID: 11472275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide 2.
    Drucker DJ
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1759-64. PubMed ID: 11297614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, secretion and biological actions of the glucagon-like peptides.
    Lovshin J; Drucker DJ
    Pediatr Diabetes; 2000 Mar; 1(1):49-57. PubMed ID: 15016242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is glucagon-like peptide 1 an incretin hormone?
    Nauck MA
    Diabetologia; 1999 Mar; 42(3):373-9. PubMed ID: 10096792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptides.
    Drucker DJ
    Diabetes; 1998 Feb; 47(2):159-69. PubMed ID: 9519708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New developments in the biology of the glucagon-like peptides GLP-1 and GLP-2.
    Drucker DJ; Lovshin J; Baggio L; Nian M; Adatia F; Boushey RP; Liu Y; Saleh J; Yusta B; Scrocchi L
    Ann N Y Acad Sci; 2000; 921():226-32. PubMed ID: 11193827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide 2: a nutrient-responsive gut growth factor.
    Burrin DG; Petersen Y; Stoll B; Sangild P
    J Nutr; 2001 Mar; 131(3):709-12. PubMed ID: 11238747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system.
    Brubaker PL; Drucker DJ
    Endocrinology; 2004 Jun; 145(6):2653-9. PubMed ID: 15044356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical endocrinology and metabolism. Glucagon-like peptide-1 and glucagon-like peptide-2.
    Baggio LL; Drucker DJ
    Best Pract Res Clin Endocrinol Metab; 2004 Dec; 18(4):531-54. PubMed ID: 15533774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COMPARATIVE GUT PHYSIOLOGY SYMPOSIUM: Comparative physiology of glucagon-like peptide-2: Implications and applications for production and health of ruminants.
    Connor EE; Evock-Clover CM; Walker MP; Elsasser TH; Kahl S
    J Anim Sci; 2015 Feb; 93(2):492-501. PubMed ID: 26020740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic properties and therapeutic potential of glucagon-like peptide-2.
    Drucker DJ; Boushey RP; Wang F; Hill ME; Brubaker PL; Yusta B
    JPEN J Parenter Enteral Nutr; 1999; 23(5 Suppl):S98-100. PubMed ID: 10483906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors.
    Holst JJ
    Expert Opin Emerg Drugs; 2004 May; 9(1):155-66. PubMed ID: 15155141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.